Clinical Trial Detail

NCT ID NCT03943173
Title Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Olaparib

Age Groups: adult senior

No variant requirements are available.